{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:55:21Z","timestamp":1791381321456,"version":"4.3.3"},"reference-count":67,"publisher":"Begell House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Caseinolytic protease P (ClpP) is a highly conserved serine protease that plays a pivotal role in protein homeostasis and quality control in bacteria, mitochondria of mammalian cells, and plant chloroplasts. As the proteolytic core of the ATP-dependent Clp protease complex, ClpP partners with regulatory ATPases (e.g., ClpX, ClpA) to degrade misfolded, damaged, or regulatory proteins. In bacteria, ClpP is crucial for survival under host-imposed stresses and modulates virulence through degradation of transcriptional regulators and signaling proteins, contributing to immune evasion, dormancy, and persistence. Particularly in pathogens like &lt;i&gt;Mycobacterium tuberculosis, Staphylococcus aureus&lt;\/i&gt;, and &lt;i&gt;Listeria monocytogenes&lt;\/i&gt;, ClpP supports intracellular adaptation and resistance, making it a promising target against antimicrobial-resistant (AMR) infections. In mammalian cells, mitochondrial ClpP ensures oxidative phosphorylation efficiency and regulates innate immunity. Loss of ClpP function can result in mitochondrial dysfunction, triggering immune activation via cytosolic leakage of mitochondrial DNA and subsequent cGAS-STING pathway stimulation. ClpP also influences cytokine production and immune cell differentiation. This dual role of ClpP in pathogen virulence and host immune modulation highlights its potential as an immunotherapeutic target. Pharmacological manipulation of ClpP activity offers novel opportunities for treating infectious diseases, inflammatory conditions, and cancer. Further investigation into ClpP's regulatory mechanisms could inform next-generation host-pathogen intervention strategies.\n<\/p>","DOI":"10.1615\/critrevimmunol.2025059878","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T18:33:08Z","timestamp":1754505188000},"page":"49-65","source":"Crossref","is-referenced-by-count":3,"title":["Caseinolytic Protease P: A Therapeutic Nexus in Infection, Inflammation, and Immunity"],"prefix":"10.1615","volume":"45","author":[{"given":"Shreya S.","family":"Sonak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharda","family":"Ishwarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Nimbarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaykumar D.","family":"Nimbarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Mabanglo MF, Houry WA. Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small molecules. J Biol Chem. 2022;298:101781.","DOI":"10.1016\/j.jbc.2022.101781"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Walker SD, Olivares AO. The activated ClpP peptidase forcefully grips a protein substrate. Biophys J. 2022;121:3907-16.","DOI":"10.1016\/j.bpj.2022.08.042"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bouchnak I, Van Wijk KJ. Structure, function, and substrates of Clp AAA+ protease systems in cyanobacteria, plastids, and apicoplasts: A comparative analysis. J Biol Chem. 2021;296:100338.","DOI":"10.1016\/j.jbc.2021.100338"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ameisen JC. On the origin, evolution, and nature of programmed cell death: A timeline of four billion years. Cell Death Differ. 2002;9:367-93.","DOI":"10.1038\/sj.cdd.4400950"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Miles J, Scherz-Shouval R, Van Oosten-Hawle P. Expanding the organismal proteostasis network: Linking systemic stress signaling with the innate immune response. Trends Biochem Sci. 2019;44:927-42.","DOI":"10.1016\/j.tibs.2019.06.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Frees D, Gerth U, Ingmer H. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. Int J Med Microbiol. 2014;304:142-9.","DOI":"10.1016\/j.ijmm.2013.11.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Forrellad MA, Klepp LI, Gioffr\u00ef\u00bf\u00bd&copy; A, Sabio Y Garcia J, Morbidoni HR, Santangelo MDLP, Virulence factors of the mycobacterium tuberculosis complex. Virulence. 2013;4:3-66.","DOI":"10.4161\/viru.22329"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Banerjee R. Tiny but mighty: Small RNAs-the micromanagers of bacterial survival, virulence, and host-pathogen interactions. ncRNA. 2025;11:36.","DOI":"10.3390\/ncrna11030036"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Illigmann A, Thoma Y, Pan S, Reinhardt L, Br\u00f6tz-Oesterhelt H. Contribution of the Clp protease to bacterial survival and mitochondrial homoeostasis. Microb Physiol. 2021;31:260-79.","DOI":"10.1159\/000517718"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Dhara A, Hussain MS, Kanaujia SP, Kumar M. Acyldepsipeptide activated ClpP1P2 macromolecule of Leptospira, an ideal Achilles' heel to hamper the cell survival and deregulate ClpP proteolytic activity. Res Micribiol. 2021;172:103797.","DOI":"10.1016\/j.resmic.2021.103797"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-Implications for human health and treatment perspectives. EMBO Rep. 2020;21:e51034.","DOI":"10.15252\/embr.202051034"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ng MYW, Wai T, Simonsen A. Quality control of the mitochondrion. Dev Cell. 2021;56:881-905.","DOI":"10.1016\/j.devcel.2021.02.009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Bohovych I, Chan SSL, Khalimonchuk O. Mitochondrial protein quality control: The mechanisms guarding mitochondrial health. Antioxid Redox Signal. 2015;22:977-94.","DOI":"10.1089\/ars.2014.6199"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Wang H, Song H, Pham AV, Cooper LJ, Schulze JJ, Olek S, Human LAP + GARP + FOXP3 + regulatory T cells attenuate xenogeneic graft versus host disease. Theranostics. 2019;9:2315-24.","DOI":"10.7150\/thno.30254"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Luna-S\u00e1nchez M, Bianchi P, Quintana A. Mitochondria-induced immune response as a trigger for neurodegeneration: A pathogen from within. Int J Mol Sci. 2021;22:8523.","DOI":"10.3390\/ijms22168523"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Xie JH, Li YY, Jin J. The essential functions of mitochondrial dynamics in immune cells. Cell Mol Immunol. 2020;17:712-21.","DOI":"10.1038\/s41423-020-0480-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lee YG, Park DH, Chae YC. Role of mitochondrial stress response in cancer progression. Cells. 2022;11:771.","DOI":"10.3390\/cells11050771"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: Foe or friend? J Biomed Sci. 2022;29:74.","DOI":"10.1186\/s12929-022-00859-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wedam R, Greer YE, Wisniewski DJ, Weltz S, Kundu M, Voeller D. Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer. Cancers. 2023;15:1936.","DOI":"10.3390\/cancers15071936"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Calvillo-Rodriguez KM, Lorenzo-Anota HY, Rodriguez-Padilla C, Martinez-Torres AC, Scott-Algara D. Immunotherapies inducing immunogenic cell death in cancer: Insight of the innate immune system. Front Immunol. 2023;14:1294434.","DOI":"10.3389\/fimmu.2023.1294434"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Cwilichowska N, Swiderska KW, Dobrzy\u00c5\u0084 A, Drag M, Poreba M. Diagnostic and therapeutic potential of protease inhibition. Mol Aspects Med. 2022;88:101144.","DOI":"10.1016\/j.mam.2022.101144"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Bhandari V, Wong KS, Zhou JL, Mabanglo MF, Batey RA, Houry WA. The role of ClpP protease in bacterial pathogenesis and human diseases. ACS Chem Biol. 2018;13:1413-25.","DOI":"10.1021\/acschembio.8b00124"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Moreno-Cinos C, Goossens K, Salado IG, Van Der Veken P, De Winter H, Augustyns K. ClpP protease, a promising antimicrobial target. Int J Mol Sci. 2019;20:2232.","DOI":"10.3390\/ijms20092232"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Choudhary E, Sharma R, Pal P, Agarwal N. Deciphering the proteomic landscape of mycobacterium tuberculosis in response to acid and oxidative stresses. ACS Omega. 2022;7:26749-66.","DOI":"10.1021\/acsomega.2c03092"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Flannagan RS, Cos\u00ef\u00bf\u00bdo G, Grinstein S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol. 2009;7:355-66.","DOI":"10.1038\/nrmicro2128"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Riboulet E, Verneuil N, La Carbona S, Sauvageot N, Auffray Y, Hartke A. Relationships between oxidative stress response and virulence in enterococcus faecalis. Microb Physiol. 2007;13:140-6.","DOI":"10.1159\/000103605"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Borez\u00e9e E, Pellegrini E, Beretti JL, Berche P. SvpA, a novel surface virulence-associated protein required for intracellular survival of Listeria monocytogenes. Microbiology. 2001;147:2913-23.","DOI":"10.1099\/00221287-147-11-2913"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Scortti M, Monz\u00f3 HJ, Lacharme-Lora L, Lewis DA, V\u00e1zquez-Boland JA. The PrfA virulence regulon. Microbes Infect. 2007;9:1196-207.","DOI":"10.1016\/j.micinf.2007.05.007"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Michel A, Agerer F, Hauck CR, Herrmann M, Ullrich J, Hacker J. Global regulatory impact of clpp protease of staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J Bacteriol. 2006;188:5783-96.","DOI":"10.1128\/JB.00074-06"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yang J, Zhang L, Qiao W, Luo Y. Mycobacterium tuberculosis: Pathogenesis and therapeutic targets. MedComm. 2023;4(5):e353.","DOI":"10.1002\/mco2.353"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Raju RM, Unnikrishnan M, Rubin DHF, Krishnamoorthy V, Kandror O, Akopian TN. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. Ehrt S, editor. PLoS Pathog. 2012;8:e1002511.","DOI":"10.1371\/journal.ppat.1002511"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Sun D, Liu Y, Peng X, Dong H, Jiang H, Fan X. ClpP protease modulates bacterial growth, stress response, and bacterial virulence in Brucella abortus. Vet Res. 2023;54:68.","DOI":"10.1186\/s13567-023-01200-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Simpson BW, Trent MS. Pushing the envelope: LPS modifications and their consequences. Nat Rev Microbiol. 2019;17:403-16.","DOI":"10.1038\/s41579-019-0201-x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Rossmann MP, Dubois SM, Agarwal S, Zon LI. Mitochondrial function in development and disease. Dis Model Mech. 2021;14(6):dmm048912.","DOI":"10.1242\/dmm.048912"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Kearney CJ, Martin SJ. An inflammatory perspective on necroptosis. Mol Cell. 2017;65:965-73.","DOI":"10.1016\/j.molcel.2017.02.024"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20:3328.","DOI":"10.3390\/ijms20133328"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Paj\u0105k B, Zieli\u0144ski R, Priebe W. The impact of glycolysis and its inhibitors on the immune response to inflammation and autoimmunity. Molecules. 2024;29:1298.","DOI":"10.3390\/molecules29061298"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Lima T, Li TY, Mottis A, Auwerx J. Pleiotropic effects of mitochondria in aging. Nat Aging. 2022;2:199-213.","DOI":"10.1038\/s43587-022-00191-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347-64.","DOI":"10.1038\/s41422-019-0164-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Heilig R, Lee J, Tait SWG. Mitochondrial DNA in cell death and inflammation. Biochem Soc Trans. 2023;51:457-72.","DOI":"10.1042\/BST20221525"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X. Mitochondrial diseases: From molecular mechanisms to therapeutic advances. Sig Transduct Target Ther. 2025;10:9.","DOI":"10.1038\/s41392-024-02044-3"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zhang G, Wei H, Zhao A, Yan X, Zhang X, Gan J. Mitochondrial DNA leakage: Underlying mechanisms and therapeutic implications in neurological disorders. J Neuroinflamm. 2025;22:34.","DOI":"10.1186\/s12974-025-03363-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Aljghami ME, Barghash MM, Majaesic E, Bhandari V, Houry WA. Cellular functions of the ClpP protease impacting bacterial virulence. Front Mol Biosci. 2022;9:1054408.","DOI":"10.3389\/fmolb.2022.1054408"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: An update. Arch Toxicol. 2016;90:1585-604.","DOI":"10.1007\/s00204-016-1727-6"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Lee YG, Kim HW, Nam Y, Shin KJ, Lee YJ, Park DH. LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival. Oncogenesis. 2021;10:18.","DOI":"10.1038\/s41389-021-00306-1"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Londe AC, Fernandez-Ruiz R, Julio PR, Appenzeller S, Niewold TB. Type I interferons in autoimmunity: Implications in clinical phenotypes and treatment response. J Rheumatol. 2023;50:1103-13.","DOI":"10.3899\/jrheum.2022-0827"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Perini T, Zordan P, Del Pizzo R, Resnati M, Viviani L, Stefanoni D. The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma. Blood. 2025. doi: 10.1182\/blood.2024026340.","DOI":"10.1182\/blood.2024026340"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Wang C, Chen L, Fu D, Liu W, Puri A, Kellis M. Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade. Clin Exp Metastasis. 2024;41:333-49.","DOI":"10.1007\/s10585-023-10257-z"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Du F, Yang L han, Liu J, Wang J, Fan L, Duangmano S. The role of mitochondria in the resistance of melanoma to PD-1 inhibitors. J Transl Med. 2023;21:345.","DOI":"10.1186\/s12967-023-04200-9"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Luo B, Ma Y, Zhou Y, Zhang N, Luo Y. Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction. Drug Discov Today. 2021;26:968-81.","DOI":"10.1016\/j.drudis.2021.01.007"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Niu H, Gu J, Zhang Y. Bacterial persisters: Molecular mechanisms and therapeutic development. Sig Transduct Target Ther. 2024;9:174.","DOI":"10.1038\/s41392-024-01866-5"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Salauddin Md, Nath SK, Saha S, Zheng Q, Zheng C, Hossain MdG. Trained immunity: A revolutionary immunotherapeutic approach. Anim Dis. 2024;4:31.","DOI":"10.1186\/s44149-024-00138-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Liu BH, Xu CZ, Liu Y, Lu ZL, Fu TL, Li GR. Mitochondrial quality control in human health and disease. Mil Med Res. 2024;11:32.","DOI":"10.1186\/s40779-024-00536-5"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Poznyak AV, Orekhov NA, Churov AV, Starodubtseva IA, Beloyartsev DF, Kovyanova TI. Mitochondrial dysfunction in systemic lupus erythematosus: Insights and therapeutic potential. Diseases. 2024;12:226.","DOI":"10.3390\/diseases12090226"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Mas-Bargues C. Mitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches. Free Radic Biol Med. 2023;208:657-71.","DOI":"10.1016\/j.freeradbiomed.2023.09.019"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Stra\u017ear M, Park J, Abelin JG, Taylor HB, Pedersen TK, Plichta DR. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery. Immunity. 2023;56:1681-98.e13.","DOI":"10.1016\/j.immuni.2023.05.009"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Mateus A, Kurzawa N, Becher I, Sridharan S, Helm D, Stein F. Thermal proteome profiling for interrogating protein interactions. Mol Syst Biol. 2020;16:e9232.","DOI":"10.15252\/msb.20199232"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Kong M, Yu Y, Shao S, Zhang C. Targeting mitochondrial ClpP: Structural insights and therapeutic potential of ClpP agonists in cancer therapy. Oncol Rev. 2025;19: 1567860.","DOI":"10.3389\/or.2025.1567860"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Moisoi N. Mitochondrial proteases modulate mitochondrial stress signalling and cellular homeostasis in health and disease. Biochimie. 2024;226:165-79.","DOI":"10.1016\/j.biochi.2024.06.005"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Przystal JM, Cianciolo Cosentino C, Yadavilli S, Zhang J, Laternser S, Bonner ER. Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas. Neuro Oncol. 2022;24:1438-51.","DOI":"10.1093\/neuonc\/noac041"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Li Q, Wu P, Du Q, Hanif U, Hu H, Li K. cGAS-STING, an important signaling pathway in diseases and their therapy. MedComm. 2024;5:e511.","DOI":"10.1002\/mco2.511"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Amitrano AM, Kim M. Metabolic challenges in anticancer CD8 T cell functions. Immune Netw. 2023;23:e9.","DOI":"10.4110\/in.2023.23.e9"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Rana S, Maharjan S, Sookdeo SD, Schmidt P. Pain management in multiple myeloma patients: A literature review. Cureus. 2024;16(3):e55975.","DOI":"10.7759\/cureus.55975"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Kim J, Li J, Wei J, Lim SA. Regulatory T cell metabolism: A promising therapeutic target for cancer treatment? Immune Netw. 2025;25(1):e13.","DOI":"10.4110\/in.2025.25.e13"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Moon J, Oh YM, Ha SJ. Perspectives on immune checkpoint ligands: Expression, regulation, and clinical implications. BMB Rep. 2021;54:403-12.","DOI":"10.5483\/BMBRep.2021.54.8.054"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Wagner J, Kline CL, Zhou L, Campbell KS, MacFarlane AW, Olszanski AJ. Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment. J Clin Invest. 2018;128:2325-38.","DOI":"10.1172\/JCI96711"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Wu SY, Fu T, Jiang YZ, Shao ZM. Natural killer cells in cancer biology and therapy. Mol Cancer. 2020;19:120.","DOI":"10.1186\/s12943-020-01238-x"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/0f241fb46f73c8c9\/CRI-59878.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:22:06Z","timestamp":1757575326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,14b65aed76c772d9,0f241fb46f73c8c9.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2025059878","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}